The role of heart rate and ivabradine in acute heart failure

https://doi.org/10.4081/monaldi.2019.1091

Authors

  • Edoardo Sciatti | edoardo.sciatti@gmail.com Cardiology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia; Cardio-Thoracic Department, ASST Spedali Civili, Brescia, Italy. http://orcid.org/0000-0002-3479-3454
  • Enrico Vizzardi Cardiology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia; Cardio-Thoracic Department, ASST Spedali Civili, Brescia, Italy.
  • Ivano Bonadei Cardiology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia; Cardio-Thoracic Department, ASST Spedali Civili, Brescia, Italy.
  • Lucia Dallapellegrina Cardiology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia; Cardio-Thoracic Department, ASST Spedali Civili, Brescia, Italy.
  • Valentina Carubelli Cardiology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia; Cardio-Thoracic Department, ASST Spedali Civili, Brescia, Italy.

Abstract

Resting heart rate (HR) is considered a powerful predictor of mortality both in healthy subjects and in cardiovascular (CV) patients, including those affected by heart failure (HF). Its reduction below 70 bpm is the treatment target in chronic HF with reduced ejection fraction (HFrEF) when sinus rhythm is present. In acute HF (AHF) HR is usually elevated but its role as risk marker is still unknown. Notably, in unstable patients, beta-blockers can be reduced or stopped, thus enhancing this phenomenon. Moreover, some data in literature suggest that HR reduction during hospitalization or HR at discharge or in the vulnerable phase after it are more predictive of early-term events and may be therapeutic targets. On the other hand, ivabradine is a pure HR-lowering drug with no effects on inotropism. Its role in the AHF setting has been recently investigated and is the object of this review.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Downloads

Published
2019-10-07
Info
Issue
Section
Cardiology - Reviews
Keywords:
Heart rate, ivabradine, acute heart failure, beta-blockers, prognosis, tachycardia
Statistics
  • Abstract views: 1382

  • PDF: 1030
How to Cite
Sciatti, Edoardo, Enrico Vizzardi, Ivano Bonadei, Lucia Dallapellegrina, and Valentina Carubelli. 2019. “The Role of Heart Rate and Ivabradine in Acute Heart Failure”. Monaldi Archives for Chest Disease 89 (3). https://doi.org/10.4081/monaldi.2019.1091.

Most read articles by the same author(s)

1 2 > >>